Skip to main content

O-Ring / Plastic Sheath Wound Retractor-Protectors

Disposable dual-function devices that combine circumferential wound retraction with an impervious plastic barrier lining the entire wound circumference — replacing the separate "self-retaining metal retractor + sterile drape" workflow with a single instrument. The Alexis O Wound Retractor/Protector (Applied Medical) is the most widely studied and reported device in the class; Mobius (CooperSurgical) and O Trac (Asung Medical) are similar dual-ring systems.[1][2][3]

Design​

Two configurations exist; dual-ring devices dominate the evidence base.[2][3]

Dual-ring (O-ring)​

  • Inner (smaller) semirigid polymer ring — compressed and inserted through the incision, then sprung open against the internal fascia / peritoneum to anchor from within.
  • Outer (larger) ring — sits on the external skin.
  • Cylindrical impervious polyurethane membrane (sheath) connects the two rings, lining the entire wound circumference and creating a sealed transabdominal tunnel.
  • Retraction is generated by rolling or twisting the outer ring, which shortens the membrane and draws the wound edges apart radially — 360° circumferential retraction without focal pressure points.[4]
  • The membrane is transparent, electrically non-conducting, and maintains wound humidity.
  • Sizes range from XXS to XL; a C-section-specific version is tailored to the Pfannenstiel.

Single-ring​

  • A single ring sits intra-abdominally, connected to an external drape. Provides protection but less effective retraction than dual-ring, and inferior SSI reduction in head-to-head meta-analysis.[2]

Available Products​

DeviceManufacturerTypeNotes
Alexis O Wound RetractorApplied MedicalDual-ringMost widely studied; XXS–XL
Alexis O C-Section RetractorApplied MedicalDual-ringSized for the transverse lower-abdominal Pfannenstiel
Alexis Laparoscopic SystemApplied MedicalDual-ring + insufflation capWound protector / extraction + pneumoperitoneum-preserving cap[6]
MobiusCooperSurgicalDual-ringSimilar to Alexis
O TracAsung MedicalDual-ringUsed in JAMA Surg 2024 Korean RCT[7]

Mechanism of SSI Reduction​

The plastic sheath protects the incision through four converging mechanisms:[2][7][8]

  • Physical barrier — blocks endogenous (enteric / peritoneal contamination) and exogenous pathogens from embedding in skin, fat, fascia, and peritoneum. A bacteriologic study of 272 patients found no positive cultures from the incision margin when a wound protector was used, even when cultures from the abdominal-cavity side of the device were positive.[8]
  • Atraumatic radial retraction — distributes force circumferentially rather than focally, preserving wound-edge perfusion (contrast with Collins / Balfour blade-edge ischemia).
  • Wound-humidity maintenance — sealed membrane prevents desiccation, preserving local tissue defense.
  • Femoral-nerve protection — no lateral blades, no psoas compression — eliminates the principal neurologic complication of metal self-retainers.[5]

Insertion Technique​

  1. Make the incision and carry it through the abdominal wall layers.
  2. Compress (fold) the inner ring and insert it through the incision into the abdominal cavity.
  3. Allow the inner ring to spring open against the internal fascia / peritoneum.
  4. Roll or twist the outer ring on the external surface — each successive roll shortens the membrane and increases radial retraction.
  5. Adjust retraction by adding or removing rolls.
  6. At case end, unroll the outer ring and remove the device by re-compressing and extracting the inner ring.

A 4-handed roll-down technique is described for transoral applications.[1]

Reconstructive-Urology and Urogyn Uses​

The plastic dual-ring wound protector is increasingly the retractor of choice for open RU / urogyn cases where the single self-retainer-plus-wound-protection combination has obvious value — particularly in clean-contaminated, contaminated, or prosthetic-implant settings:

  • Open urinary diversion / radical cystectomy / continent cutaneous pouch — bowel anastomosis through a transversely-protected sheath, with the device replacing a Balfour for wound retraction at the time the bowel is open.
  • Augmentation cystoplasty and bowel-segment harvest — protects the incision during enterotomy and reservoir construction.
  • Open neobladder / Indiana pouch creation — particularly through Pfannenstiel; an Alexis-vs-Collins-style decision in non-obese patients.
  • Open AUS / IPP reservoir and pump-pouch placement — prosthetic-implant cases where the wound barrier function is a direct device-protection argument, and the Mulcahy salvage literature supports any incremental contamination-reduction step.
  • Open sacrocolpopexy, urethral diverticulectomy, complex VVF / RVF / vaginoplasty — when a transverse lower-abdominal access is used.
  • Specimen extraction in laparoscopic / robotic RU — vaginal or Pfannenstiel mini-laparotomy specimen extraction during robotic cystectomy, partial nephrectomy, or sacrocolpopexy revision.
  • Pediatric urology — small Alexis sizes for hypospadias, Mitrofanoff, augmentation through limited incisions.

Evidence — SSI Reduction​

General abdominal / GI surgery​

The Korean multicenter RCT (JAMA Surg 2024, n = 458) of dual-ring wound protector vs conventional surgical gauze in open GI surgery found a 46.8% relative reduction in SSI (10.9% vs 20.5%; RRR 46.81%, 95% CI 16.64–66.06%).[7]

Colorectal surgery​

A 2026 meta-analysis of 6 RCTs (666 patients) showed wound protectors significantly reduced SSI in open colorectal surgery (RR 0.44, 95% CI 0.22–0.88). Subgroup analysis of Alexis O-ring specifically showed an even greater effect — RR 0.21 (95% CI 0.09–0.48, p < 0.001).[9] The ASCRS 2024 guideline gives a strong recommendation for wound-protector use in colorectal surgery (high-quality evidence).[10]

Cesarean section — mixed, BMI-dependent​

  • Non-obese, first planned cesarean (Charité 2016): SSI 1% vs 8% favoring Alexis over Collins (p = 0.035).[5]
  • Obese (median BMI 40): no benefit — 20.6% vs 17.6% (p = 0.62).[11]
  • Meta-analysis (Waring 2018, 6 RCTs, 1,669 women): no overall SSI reduction at cesarean (RR 0.76, 95% CI 0.34–1.70); benefit limited to a non-obese / BMI < 30 subgroup.[12]

Dual-ring vs single-ring​

A meta-analysis of 16 RCTs (3,695 patients) demonstrated dual-ring superiority (RR 0.29, 95% CI 0.15–0.55) over single-ring devices (RR 0.71, 95% CI 0.54–0.92).[2][10][13] The WSES 2020 position rates dual-ring superiority as Grade 1B.[2]

Guideline Positioning​

SocietyRecommendationStrength
WHO 2016Use wound protectors in clean-contaminated, contaminated, and dirty abdominal surgeryConditional (very low quality)[3]
WSES 2020Dual-ring devices superior to single-ring for SSI preventionGrade 1B[2]
ASCRS 2024Wound protectors decrease SSI after colorectal surgeryStrong (high quality)[10]

Off-Label / Novel Applications​

The Alexis platform has been adapted well beyond its original abdominal-retractor role:[1][4][6][14][15]

  • Transoral robotic surgery (TORS) — intraoral self-retaining retraction for tonsillectomy, pharyngoplasty, and head-and-neck tumor resection; protects lips and mucosa; electrically non-conducting.[1][14]
  • Transoral robotic thyroidectomy — vestibular-incision sealed tunnel that accommodates CO₂ insufflation around the SP cannula.[15]
  • Ventriculoperitoneal shunt surgery — abdominal-zone visualization for single-surgeon free-hand placement, particularly in obese patients.[4]
  • Giant ovarian-cyst aspiration and resection — Alexis Laparoscopic System enables minimally invasive cyst control with oncologic safety, then converts to laparoscopy via the insufflation cap.[6]
  • Vaginal specimen extraction in robotic / laparoscopic intra-abdominal resections.[1]
  • Gastroschisis staged reduction in neonatal surgery.[1]
  • Double-retractor technique — one Alexis inside another to retract two surgical planes (e.g., esophageal hiatus stabilization).[1]
  • Urologic prosthetics — wound barrier during IPP / AUS implantation.[1]

Advantages vs Traditional Metal Retractors​

  • 360° circumferential, focal-pressure-free retraction — no femoral-nerve compression risk.[5]
  • Physical barrier against endogenous and exogenous wound contamination.[2][8]
  • Atraumatic — preserves wound-edge perfusion.
  • Electrically non-conducting — safe with monopolar and bipolar energy.[1]
  • Self-retaining once rolled — no assistant needed.
  • Transparent — wound-edge visualization.

Disadvantages​

  • Disposable / single-use — higher per-case cost than reusable Balfour / Collins.
  • No central / cephalad blade — does not provide directed retraction of the bladder flap or any specific structure the way the Balfour family does; usually combined with handheld Deaver or malleable retractors for deep pelvic exposure.
  • Size-sensitive — under-sized devices retract inadequately; over-sized devices fail to anchor.
  • Attenuated benefit in obese patients — BMI ≥ 35 in cesarean, with possible loss of advantage at extreme BMI.[11][12]
  • Contamination at insertion / removal — some bacterial transfer occurs at the moments the device is not yet (or no longer) sealed.[2]

Cost-Effectiveness​

The cost-effectiveness of disposable plastic wound protectors vs reusable metal retractors is context-dependent and turns on three variables: device type (dual- vs single-ring), surgical setting (baseline SSI rate), and the per-case cost of an SSI in the local healthcare system. The headline pattern: dual-ring devices are dominant in colorectal / contaminated GI surgery, equivocal-to-unfavorable in mixed low-risk laparotomy with single-ring devices.[16][17]

Cost framework​

  • Alexis wound retractor / protector: ~$30–80 per disposable unit depending on size and contract.
  • Reusable metal retractor (Balfour, Collins): ~$500–2,000 initial purchase, ~$5–15 per sterilization cycle, amortized over thousands of cases.
  • Cost of treating one SSI (US): ~$12,000–25,000+ — driven by extended hospitalization, antibiotics, wound care, readmission, and reoperation.[16][18]

At an absolute risk reduction of 10–20% in colorectal surgery (NNT 5–10), the cost to prevent one SSI with a dual-ring device is **$250–800** — versus a $12,000–25,000 treatment cost. The arithmetic dominates wherever baseline SSI risk is high.

Favorable evidence — colorectal / GI surgery​

A formal decision-analytic cost-effectiveness analysis (Chomsky-Higgins & Kahn 2019) found dual-ring wound protectors dominant (better outcomes and lower total cost) in colorectal surgery:[16]

  • +230 QALYs per 1,000 patients vs no intervention.
  • $2.2 million per 1,000 patients in cost savings, driven by SSI-treatment avoidance.
  • Dual-ring devices held a distinct advantage over single-ring alternatives.

Unfavorable evidence — ROSSINI trial (mixed laparotomy, single-ring)​

The ROSSINI trial economic evaluation (Gheorghe 2014, n = 760) in UK general laparotomy found wound protectors not cost-effective:[17]

  • Mean cost £5,420 (protector) vs £5,130 (standard).
  • QALYs essentially identical (0.02131 vs 0.02133).
  • More costly, equally effective — robust to sensitivity analysis.

ROSSINI used a single-ring device in a population with a lower baseline SSI rate than colorectal surgery, and subsequent meta-analyses show single-ring devices (RR 0.71) are far less protective than dual-ring (RR 0.29).[2][10][19] The ROSSINI conclusion does not generalize to dual-ring devices in high-SSI-risk surgery.

Reconciling the two​

FactorFavors cost-effectivenessAgainst
DeviceDual-ring (RR 0.29)Single-ring (RR 0.71)
SettingColorectal, contaminated GI, prosthetic implant (high baseline SSI)Clean / mixed low-risk laparotomy
PatientNon-obeseObese cesarean (BMI ≥ 35 — benefit attenuated)[11][12]
SystemHigh SSI-treatment cost (US)Lower SSI-treatment cost (NHS)

Exposure-per-incision-length advantage​

Beyond SSI prevention, an animal-tissue exposure study found the Alexis provides significantly more surgical surface area per incision length than traditional metal self-retainers — for a 5-cm incision, 12.25 cm² (Alexis small) vs 6.17 cm² (Mollison), p = 0.038 — supporting the use of shorter incisions with equivalent exposure, which may further reduce wound-complication and recovery cost.[20]

Guideline cost framing​

  • WHO 2016 — explicitly notes that wound-protector use "should not always be prioritised in low-resource settings over other interventions" given cost and availability.[3]
  • ASCRS 2024 — strong recommendation in colorectal surgery, implicitly endorsing the cost-benefit at the high-baseline-SSI end.[10]
  • SHEA/IDSA 2022 update — includes wound protectors among essential SSI-prevention practices in acute-care hospitals (~30% SSI reduction with dual-ring).[21]

RU / urogyn implications​

The dominant-cost case is strongest for the RU / urogyn settings that combine bowel work + a prosthetic or high-stakes reconstruction: open urinary diversion, augmentation cystoplasty, continent cutaneous pouch, and any open AUS / IPP placement where the wound-protector barrier function compounds the standard SSI-reduction argument. In low-risk, clean Pfannenstiel work (open sacrocolpopexy in a non-obese patient, urethral diverticulectomy), the cost case is weaker and the choice is driven more by per-case workflow than by economics.

  • Collins and Balfour — metal wound-edge self-retainers; reusable; the comparators in the cesarean and abdominal-surgery RCTs.
  • Bookwalter, Omni-Tract, Thompson — table-mounted ring systems for deeper / longer cases.
  • Lone Star and Denis Browne — elastic / circumferential ring retractors that share the "circumferential, focal-pressure-free" mechanical principle for perineal / vaginal / pediatric work.

References​

1. Perenyei M, Dobbs TD, Fraser LR, Winter SC. Use of the self-retaining Alexis ring retractor in transoral robotic surgery. Head Neck. 2017;39(10):2132-2134. doi:10.1002/hed.24882

2. De Simone B, Sartelli M, Coccolini F, et al. Intraoperative surgical site infection control and prevention: a position paper and future addendum to WSES intra-abdominal infections guidelines. World J Emerg Surg. 2020;15(1):10. doi:10.1186/s13017-020-0288-4

3. Allegranzi B, Zayed B, Bischoff P, et al. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016;16(12):e288-e303. doi:10.1016/S1473-3099(16)30402-9

4. Krauss P, Oertel MF, Stieglitz LH. Introduction of a self-holding retractor for optimized abdominal visualization in ventriculoperitoneal shunt surgery: first experiences at a single center. Acta Neurochir. 2019;161(7):1361-1365. doi:10.1007/s00701-018-03794-0

5. Hinkson L, Siedentopf JP, Weichert A, Henrich W. Surgical site infection in cesarean sections with the use of a plastic sheath wound retractor compared to the traditional self-retaining metal retractor. Eur J Obstet Gynecol Reprod Biol. 2016;203:232-8. doi:10.1016/j.ejogrb.2016.06.003

6. Dubuisson J, Fehlmann A, Petignat P. Management of presumed benign giant ovarian cysts: a minimally invasive technique using the Alexis Laparoscopic System. J Minim Invasive Gynecol. 2015;22(4):540. doi:10.1016/j.jmig.2015.01.027

7. Yoo N, Mun JY, Kye BH, et al. Plastic wound protector vs surgical gauze for surgical site infection reduction in open GI surgery: a randomized clinical trial. JAMA Surg. 2024;159(7):737-746. doi:10.1001/jamasurg.2024.0765

8. Horiuchi T, Tanishima H, Tamagawa K, et al. A wound protector shields incision sites from bacterial invasion. Surg Infect (Larchmt). 2010;11(6):501-3. doi:10.1089/sur.2009.072

9. Desai A, Bisht R, Misra S, et al. Efficacy of wound protectors in reducing surgical site infections in patients undergoing open colorectal surgery: a systematic review and meta-analysis. Colorectal Dis. 2026;28(2):e70401. doi:10.1111/codi.70401

10. Shogan BD, Vogel JD, Davis BR, et al. The American Society of Colon and Rectal Surgeons clinical practice guidelines for preventing surgical site infection. Dis Colon Rectum. 2024;67(11):1368-1382. doi:10.1097/DCR.0000000000003450

11. Scolari Childress KM, Gavard JA, Ward DG, Berger K, Gross GA. A barrier retractor to reduce surgical site infections and wound disruptions in obese patients undergoing cesarean delivery: a randomized controlled trial. Am J Obstet Gynecol. 2016;214(2):285.e1-285.e10. doi:10.1016/j.ajog.2015.09.096

12. Waring GJ, Shawer S, Hinshaw K. The use of O-ring retractors at caesarean section: a systematic review and meta analysis. Eur J Obstet Gynecol Reprod Biol. 2018;228:209-214. doi:10.1016/j.ejogrb.2018.06.037

13. Kang SI, Oh HK, Kim MH, et al. Systematic review and meta-analysis of randomized controlled trials of the clinical effectiveness of impervious plastic wound protectors in reducing surgical site infections in patients undergoing abdominal surgery. Surgery. 2018;164(5):939-945. doi:10.1016/j.surg.2018.05.024

14. Lee J, Yu JW, Lee ZH, Levine JP, Jacobson AS. Alexis retractor: institutional experience of its applications in head and neck surgery and review of the literature. Cleft Palate Craniofac J. 2020;57(5):656-659. doi:10.1177/1055665619900833

15. Park D, Shaear M, Chen YH, et al. Transoral robotic thyroidectomy on two human cadavers using the Intuitive da Vinci single port robotic surgical system and CO₂ insufflation: preclinical feasibility study. Head Neck. 2019;41(12):4229-4233. doi:10.1002/hed.25939

16. Chomsky-Higgins K, Kahn JG. Interventions and innovation to prevent surgical site infection in colorectal surgery: a cost-effectiveness analysis. J Surg Res. 2019;235:373-382. doi:10.1016/j.jss.2018.09.048

17. Gheorghe A, Roberts TE, Pinkney TD, et al. The cost-effectiveness of wound-edge protection devices compared to standard care in reducing surgical site infection after laparotomy: an economic evaluation alongside the ROSSINI trial. PLoS One. 2014;9(4):e95595. doi:10.1371/journal.pone.0095595

18. Cheng KP, Roslani AC, Sehha N, et al. Alexis O-ring wound retractor vs conventional wound protection for the prevention of surgical site infections in colorectal resections. Colorectal Dis. 2012;14(6):e346-51. doi:10.1111/j.1463-1318.2012.02943.x

19. Zhang L, Elsolh B, Patel SV. Wound protectors in reducing surgical site infections in lower gastrointestinal surgery: an updated meta-analysis. Surg Endosc. 2018;32(3):1111-1122. doi:10.1007/s00464-017-6012-0

20. Lawson J, McGill A, Meares H, et al. Wound protectors for improved exposure in open hernia repair. Hernia. 2019;23(6):1215-1219. doi:10.1007/s10029-019-01952-6

21. Calderwood MS, Anderson DJ, Bratzler DW, et al. Strategies to prevent surgical site infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol. 2023;44(5):695-720. doi:10.1017/ice.2023.67